Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nunes

Showing results (91-100 of 609) with videos related to

Pageof 61
Sort By:
Addiction (Abingdon, England)|March 27, 2015
Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'Frances R Levin, John J Mariani, Adam Bisaga, et al.
Seminars in Clinical Neuropsychiatry|July 12, 2001
Pathological gambling: addiction or compulsion?C Blanco, P Moreyra, E V Nunes, et al.
Current Opinion in Psychiatry|September 16, 2011
Current pharmacological approaches and perspectives in the treatment of geriatric mood disordersBreno S Diniz, Paula V Nunes, Rodrigo Machado-Vieira, et al.
Human Mutation|March 29, 2000
Detection of two novel large deletions in SLC3A1 by semi-quantitative fluorescent multiplex PCRJ Purroy, L Bisceglia, J Jaeken, et al.
The American Journal of Drug and Alcohol Abuse|March 16, 2000
Venlafaxine treatment of cocaine abusers with depressive disordersD M McDowell, F R Levin, A M Seracini, et al.
Drug and Alcohol Dependence|April 22, 2004
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trialKenneth M Carpenter, Adam C Brooks, Suzanne K Vosburg, et al.
Human Genetics|April 9, 2005
Gene symbol: SLC3A1. Disease: cystinuriaV Nunes, M Font-Llitjós, M Jiménez-Vidal, et al.
Drug and Alcohol Dependence|May 24, 2023
Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinenceLaura Brandt, Mei-Chen Hu, Edward V Nunes, et al.
Human Molecular Genetics|January 1, 1993
A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotypeV Nunes, M Chillón, T Dörk, et al.
Journal of Substance Abuse Treatment|December 24, 2017
Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSATPeter D Friedmann, Kelly E Dunn, Edward V Nunes, et al.
Pageof 61

Showing results (91-100 of 609) with videos related to

Sort By:
Pageof 61
Addiction (Abingdon, England)|March 27, 2015
Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'Frances R Levin, John J Mariani, Adam Bisaga, et al.
Seminars in Clinical Neuropsychiatry|July 12, 2001
Pathological gambling: addiction or compulsion?C Blanco, P Moreyra, E V Nunes, et al.
Current Opinion in Psychiatry|September 16, 2011
Current pharmacological approaches and perspectives in the treatment of geriatric mood disordersBreno S Diniz, Paula V Nunes, Rodrigo Machado-Vieira, et al.
Human Mutation|March 29, 2000
Detection of two novel large deletions in SLC3A1 by semi-quantitative fluorescent multiplex PCRJ Purroy, L Bisceglia, J Jaeken, et al.
The American Journal of Drug and Alcohol Abuse|March 16, 2000
Venlafaxine treatment of cocaine abusers with depressive disordersD M McDowell, F R Levin, A M Seracini, et al.
Drug and Alcohol Dependence|April 22, 2004
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trialKenneth M Carpenter, Adam C Brooks, Suzanne K Vosburg, et al.
Human Genetics|April 9, 2005
Gene symbol: SLC3A1. Disease: cystinuriaV Nunes, M Font-Llitjós, M Jiménez-Vidal, et al.
Drug and Alcohol Dependence|May 24, 2023
Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinenceLaura Brandt, Mei-Chen Hu, Edward V Nunes, et al.
Human Molecular Genetics|January 1, 1993
A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotypeV Nunes, M Chillón, T Dörk, et al.
Journal of Substance Abuse Treatment|December 24, 2017
Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSATPeter D Friedmann, Kelly E Dunn, Edward V Nunes, et al.
Pageof 61